Organic compounds -- part of the class 532-570 series – Organic compounds – Carbohydrates or derivatives
Reexamination Certificate
2006-05-30
2006-05-30
Ungar, Susan (Department: 1642)
Organic compounds -- part of the class 532-570 series
Organic compounds
Carbohydrates or derivatives
Reexamination Certificate
active
07053193
ABSTRACT:
The present invention relates to all facets of novel polynucleotides, the polypeptides they encode, antibodies and specific binding partners thereto, and their applications to research, diagnosis, drug discovery, therapy, clinical medicine, forensic science and medicine, etc. The polynucleotides, Urb-ctf, are expressed in breast cancer and are therefore useful in variety of ways, including, but not limited to, as molecular markers, as drug targets, and for detecting, diagnosing, staging, monitoring, prognosticating, preventing or treating, determining predisposition to, etc., diseases and conditions especially related to breast cancer.
REFERENCES:
patent: 5912143 (1999-06-01), Bandman et al.
Thompson et al (GEnome Research, 2002, 12:1517-1622.
Soares et al PNAS, 1994, 91:9228-9322).
Yerushalmi et al 9Gene, 2001, 263:55-60).
Caillou et al (J. Clinical Endocrinology and Metabolism, 2001, 86:335 ‘-335’).
Sambrook (A Laboratory Manual, 2nd Ed., Sambrook et al, Eds, 1989, Cold Spring Harbor Laboratory Press, p. .6).
Old and Primrose (Principles of Gene Manipulation, An Introduction to Genetic Engineering, 1989, Blackwell Scientific Publications, Osney Mead, Oxfor, p. 122.
Jansen et al., 1995, Pediatric Research, 37(6):681-686).
Alberts et al (Molecular Biology of the Cell, 3rd Ed., 1994, p. 465).
Shantz and Pegg (Int. J. Biochem and Cell Biol., 1999, 31:107-122).
Fu et al (EMBO J. 1996, 15:4392-4401).
Brennan et al (J. Autoimunity, 1989, 2 suppl:177-186).
Zimmer (Cell Motility and the Cytoskeleton, 1991, 20:325-337).
Eriksson et al (Diabetologia, 1992, 35:143-147).
Hell et al (Lab. Invest., 1995, 73:492-496).
Powell et al (Pharmacogenesis, 1998, 8:411-421).
Carrere et al (Gut, 1999, 44:550-551).
Vallejo et al (Biochimie, 2000, 82:1129-1133).
Guo et al (J. Pharm. Exp. Therapeutics, 2002, 300,:206-212).
Jang et al 9Clinical and Experimental Metastasis, 1997, 15:469-483).
Bork (Genome Research, 2000, 10:398-400).
Scottt et al (Nature Genetics, 1999, 21:440-443).
Bowie et al (Science, 1990, 257:1306-1310).
Burgess et al (j. Cell Bio., 1990, 111::2129-2138).
Lazar et al (Mol. Cell. Biol., 1988, 8:1247-1252).
Harris et al (J. Am. Soc. Nephrology, 1995, 6:1125-1133).
Ahn et al (Nature Genetics, 1993, 3(4):283-291).
Cawthon et al (Genomics, 1991, 9(3):446-460).
Konno et al (Al049450)Genbank Sequence Database, National Center for Biotechnology Information, National Library of Medicine, Bethesda, Maryland, publicly available Jun. 23, 2000).
Boehringer Mannheim Biochemicals, 1994, Catalog, p. 93.
Carninci et al (GEnome Research, 2000, 10(10)1617-1630).
Shibata et al (Genome Research, 2000, 10(1)1757-1771).
Reiger et al (Glossary of Genetics and togenetics, Classical and Molecular, 4th Ed., Springer-Verlag, Berline, 1976, p. 17).
XM—058887. NCBI Sequence Revision History and Sequence Record Dated Dec. 10, 2001.
AK014463. NCBI Sequence Revision History and Sequence Record Dated Jan. 19, 2002.
Fan Wufang
Jay Gilbert
Kovacs Karl F.
Li Xuan
Sun Zairen
Millen White Zelano & Branigan P.C.
Origene Technologies, Inc.
Ungar Susan
LandOfFree
Breast cancer transcription factor gene and uses does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Breast cancer transcription factor gene and uses, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Breast cancer transcription factor gene and uses will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3604026